Our CEO, Ian Wilson, and members of our BD Team, will be attending the 40th Annual J.P. Morgan Health Care Conference.
If you would like to find out more about our market leading CD8 ImmunoPET technology and how it may improve decision making in early IO clinical trials, then why not get in touch with us at info@imaginab.com and we can arrange an 'in person' or virtual meeting.
More information on the conference can be found here
